Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)-Reference-Cited by-同舟云学术

Perioperative chemotherapy with docetaxel, cisplatin and capecitabine (DCX) in gastro-oesophageal adenocarcinoma: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Published:2012-11 Issue:11 Volume:23 Page:2827-2834
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Thuss-Patience P.C.,Hofheinz R.D.,Arnold D.,Florschütz A.,Daum S.,Kretzschmar A.,Mantovani-Löffler L.,Bichev D.,Breithaupt K.,Kneba M.,Schumacher G.,Glanemann M.,Schlattmann P.,Reichardt P.,Gahn B.

Funder

Roche and Sanofi-Aventis

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/23/11/2827/13786760/mds129.pdf

Reference35 articles.

1. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

3. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: A FNCLCC and FFCD multicenter phase III Trial;Ychou;J Clin Oncol,2011